Loading...

Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety

Despite the introduction of immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and, more recently, monoclonal antibodies (mAbs), in the chemotherapy regimens for newly diagnosed (NDMM) and relapsed/refractory MM (RRMM), the occurrence of drug resistance remains a challenge in MM patients....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Des Devel Ther
Main Authors: Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Olivieri, Attilio
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8180291/
https://ncbi.nlm.nih.gov/pubmed/34103900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S267404
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!